Hereditary Testing Market Report 2026: Strategic Insights and Revenue Outlook

Uncover key drivers, emerging technologies, and competitive movements shaping the hereditary testing market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Hereditary Testing Market?

The hereditary testing market size has seen substantial growth in recent years. It is anticipated to increase from $6.62 billion in 2025 to $7.23 billion in 2026, with a compound annual growth rate (CAGR) of 9.2%. The expansion observed in prior periods is linked to advancements in genetic sequencing technologies, greater public awareness of inherited disorders, the proliferation of clinical genetics programs, a decrease in the cost of genetic testing, and the development of diagnostic laboratory networks.

The hereditary testing market is poised for robust expansion over the coming years. Its valuation is projected to reach $10.17 billion by 2030, progressing at a compound annual growth rate of 8.9%. This anticipated growth during the forecast period stems from factors such as the greater incorporation of genomics into standard medical practices, an escalating need for precision medicine solutions, the broadening of genetic screening initiatives across populations, the increasing deployment of digital platforms for genetic data, and a heightened emphasis on genomics for preventative healthcare. Key developments anticipated during this timeframe involve the wider acceptance of next-generation sequencing assays, a surging interest in genetic tests for prediction and carrier status, the increasing application of AI in interpreting genetic variants, the broadening scope of prenatal and newborn screening initiatives, and a stronger emphasis on individualized genetic counseling services.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25782&type=smp

Which Drivers Are Supporting The Rise Of The Hereditary Testing Market?

The rising occurrence of genetic conditions is anticipated to fuel expansion in the hereditary testing market. These disorders are defined as health issues stemming from DNA irregularities or changes, which can be passed down from parents or emerge without a familial history. A contributing factor to the increase in genetic disorders is the rising age of parents, elevating the probability of transmitting genetic mutations to their children. Hereditary testing aids individuals with genetic disorders by facilitating prompt diagnosis, directing tailored therapies, and assisting family planning by pinpointing inherited mutations. An example is provided by the Cystic Fibrosis Trust, a UK-based charitable organization, which reported in October 2024 that the count of individuals registered with cystic fibrosis grew to 11,318 in 2023, an increase from 11,148 in 2022. Consequently, the expanding occurrence of genetic conditions is boosting the hereditary testing market’s growth.

What Leading Segments Are Studied In The Hereditary Testing Market?

The hereditary testing market covered in this report is segmented –

1) By Test Type: Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Diagnostic Testing, Other Test Types

2) By Sample Type: Blood Samples, Saliva Samples, Tissue Samples, Buccal Swabs, Amniotic Fluid And Cord Blood Samples

3) By Technology Used: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Sanger Sequencing, Microarray Technology, Whole Genome Sequencing (WGS)

4) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Metabolic Disorders, Other Applications

5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Patients And Consumers

Subsegments:

1) By Predictive Testing: Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Gene Mutation Testing, Lynch Syndrome Testing, Familial Hypercholesterolemia Testing, Huntington’s Disease Testing, Cardiomyopathy Genetic Testing

2) By Carrier Testing: Cystic Fibrosis Carrier Screening, Tay-Sachs Carrier Screening, Spinal Muscular Atrophy (SMA) Carrier Screening, Thalassemia Carrier Screening, Sickle Cell Carrier Testing

3) By Prenatal Testing: Non-Invasive Prenatal Testing (NIPT), Chorionic Villus Sampling (CVS), Amniocentesis, Expanded Carrier Screening (Prenatal Context), Cell-Free Fetal Deoxyribonucleic Acid Testing

4) By Newborn Screening: Phenylketonuria (PKU) Screening, Congenital Hypothyroidism Screening, Cystic Fibrosis Screening, Sickle Cell Disease Screening, Hearing Loss and Metabolic Disorder Panels

5) By Diagnostic Testing: Rare Disease Genetic Testing, Inherited Cancer Diagnostic Testing, Cardiogenetic Diagnostic Panels, Neurogenetic Disorder Testing, Monogenic Disease Panels

6) By Other Test Types: Pharmacogenomics Testing, Preimplantation Genetic Diagnosis (PGD), Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), Mitochondrial Deoxyribonucleic Acid Testing

How Are Emerging Trends Affecting The Progression Of The Hereditary Testing Market?

Leading companies within the hereditary testing market are concentrating on technological improvements in genetic test kits to elevate testing precision, decrease turnaround times, and broaden the detection range for genetic mutations. Genetic test kits are defined as diagnostic instruments that analyze an individual’s deoxyribonucleic acid (DNA) to identify genetic mutations or variations associated with inherited conditions or disease predispositions. For instance, in July 2023, Devyser Diagnostics AB, a Sweden-based biotechnology company specializing in the creation, manufacturing, and distribution of DNA diagnostic kits for hereditary disease testing, launched two novel targeted next-generation sequencing kits: Devyser LynchFAP and Devyser BRCA PALB2. Devyser LynchFAP uniquely facilitates the comprehensive analysis of PMS2, effectively addressing challenges from its pseudogene PMS2CL, alongside nine other crucial genes linked to hereditary colorectal cancer syndromes. Devyser BRCA PALB2 provides a seamless, single-tube solution for screening BRCA1, BRCA2, and PALB2 mutations in both blood and tumor samples. These solutions are engineered for optimized lab workflows, delivering efficient, user-friendly sequencing and dedicated software to support the confident identification of hereditary cancer risks.

Which Key Players Are Driving Competition In The Hereditary Testing Market?

Major companies operating in the hereditary testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., CooperSurgical Inc., QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, GeneDx LLC, Twist Bioscience Corporation, Color Health Inc., MedGenome Inc, SOPHiA GENETICS SA, Gene By Gene Ltd., Dante Labs Inc., 23mofang Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hereditary-testing-global-market-report

Which Region Currently Holds The Largest Share Of The Hereditary Testing Market?

North America was the largest region in the hereditary testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hereditary Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25782&type=smp

Browse Through More Reports Similar to the Global Hereditary Testing Market 2026, By The Business Research Company

Prenatal And Newborn Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Dna Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795